Y. Alayed

发表

Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancer.

P. Cheung, E. Szumacher, D. Vesprini, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.

Hans T. Chung, Liying Zhang, B. McCurdy, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation.

Hans T. Chung, Liying Zhang, P. Cheung, 2019, International journal of radiation oncology, biology, physics.

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT).

Hans T. Chung, Liying Zhang, B. McCurdy, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluating the tolerability of a simultaneous focal boost to the gross tumour in prostate SABR: a toxicity and quality of life comparison of two prospective trials.

P. Cheung, L. D'alimonte, N. Mittmann, 2020, International journal of radiation oncology, biology, physics.

Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients.

P. Cheung, E. Szumacher, D. Vesprini, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Saudi Lymphoma Group‘s Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic

Mubarak M. Al-Mansour, A. Alhejazi, J. Apostolidis, 2020, Saudi journal of medicine & medical sciences.

Radiotherapy for patients with unresected locally advanced breast cancer.

Liying Zhang, H. Soliman, D. Vesprini, 2018, Annals of palliative medicine.

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.

P. Cheung, L. D'alimonte, D. Loblaw, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric impact of tracheostomy devices in head and neck cancer patients

A. Kim, A. Ravi, S. Ramadan, 2020, Journal of applied clinical medical physics.

MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial.

Laura D'Alimonte, Hans T. Chung, Ananth Ravi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate Bed.

Liying Zhang, P. Cheung, A. Gladwish, 2019, Practical radiation oncology.

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Liying Zhang, P. Cheung, M. McGuffin, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability

Katherine A. Vallis, Nadia Falzone, K. Vallis, 2018, The Journal of Nuclear Medicine.

Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial.

Liying Zhang, P. Cheung, W. Chu, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials.

Liying Zhang, B. McCurdy, P. Cheung, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.